Back to today’s briefing

Story perspectives

First-Ever Canine Cancer Immunotherapy Receives USDA Approval

3/19/2025

49 6

Summary

Story summary

ELIAS Animal Health has achieved a groundbreaking milestone with full USDA approval for its ELIAS Cancer Immunotherapy (ECI), the first-ever autologous treatment for canine osteosarcoma. This innovative therapy harnesses the power of a dog’s immune system to combat cancer cells, following a surgical procedure for tissue collection, and is now accessible at 100 authorized centers nationwide.

1 of 1

Story summary

ELIAS Animal Health has achieved a groundbreaking milestone with full USDA approval for its ELIAS Cancer Immunotherapy (ECI), the first-ever autologous treatment for canine osteosarcoma. This innovative therapy harnesses the power of a dog’s immune system to combat cancer cells, following a surgical procedure for tissue collection, and is now accessible at 100 authorized centers nationwide.